Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.
The extracellular Ca(2+)-sensing receptor (CaSR) plays an essential role in extracellular Ca(2+) homeostasis by regulating the rate of parathyroid hormone (PTH) secretion and the rate of calcium reabsorption by the kidney. Activation of the renal CaSR is thought to inhibit paracellular divalent cation reabsorption in the cortical ascending limb (cTAL) both directly and indirectly via a decrease in NaCl transport. However, in patients with autosomal dominant hypocalcemia (ADH), caused by CaSR gain-of-function mutations, a defect in tubular NaCl reabsorption with renal loss of NaCl has not been described so far. This article describes a patient with ADH due to a gain-of-function mutation in the CaSR, L125P, associated with a Bartter-like syndrome that is characterized by a decrease in distal tubular fractional chloride reabsorption rate and negative NaCl balance with secondary hyperaldosteronism and hypokalemia. The kinetics of activation of the L125P mutant receptor expressed in HEK-293 cells, assessed by measuring CaSR-stimulated changes in intracellular Ca(2+) and ERK activity, showed a dramatic reduction in the EC(50) for extracellular Ca(2+) compared with the wild-type and a loss-of-function mutant CaSR (I40F). This study describes the first case of ADH associated with a Bartter-like syndrome. It is herein proposed that the L125P mutation of the CaSR, which represents the most potent gain-of-function mutation reported so far, may reduce NaCl reabsorption in the cTAL sufficiently to result in renal loss of NaCl with secondary hyperaldosteronism and hypokalemia.
Vargas-Poussou
Rosa
R
Inserm U423, Department of Physiology, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France. vargas@necker.fr
Huang
Chunfa
C
Hulin
Philippe
P
Houillier
Pascal
P
Jeunemaître
Xavier
X
Paillard
Michel
M
Planelles
Gabrielle
G
Déchaux
Michèle
M
Miller
R Tyler
RT
Antignac
Corinne
C
D001477:Bartter Syndrome / Q000235:genetics* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D004252:DNA Mutational Analysis; D015870:Gene Expression / Q000502:physiology; D005799:Genes, Dominant; D006801:Humans; D006996:Hypocalcemia / Q000235:genetics* / Q000378:metabolism; D066298:In Vitro Techniques; D007231:Infant, Newborn; D007668:Kidney / Q000166:cytology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D016297:Mutagenesis, Site-Directed / Q000502:physiology; D044169:Receptors, Calcium-Sensing; D011956:Receptors, Cell Surface / Q000235:genetics* / Q000378:metabolism*; D012965:Sodium Chloride / Q000378:metabolism
D044169:Receptors, Calcium-Sensing; D011956:Receptors, Cell Surface; D012965:Sodium Chloride; D002118:Calcium